이종석 프로필 사진

이종석

Lee, Jong Seok

자료 필터

자료유형

발행연도

2007 ~ 2022
2007 2022

키워드

언어

전체 10건 중 1번부터 10번까지의 결과를 표시합니다.

2022
2021
2020
Conference

Efficacy and safety of lazertinib 240 mg as the clinical dose in patients with EGFR T790M mutant NSCLC: Data from a phase I/II study.

  • 2020-05-20
  • 미국
Conference

Diagnostic accuracy of CT-staging of advanced gastric cancer following neoadjuvant chemotherapy.

  • 2020-05-20
  • 미국
Conference

ctDNA resistance landscape of lazertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI).

  • 2020-05-20
  • 미국
Conference

Intracranial anti-tumor activity of lazertinib in patients with advanced NSCLC who progressed after prior EGFR TKI therapy: Data from a phase I/II study.

  • 2020-05-20
  • 미국
2019
Conference

Lazertinib, a 3rd generation EGFR-TKI, in patients with EGFR-TKI resistant NSCLC: Updated results of phase I/II Study.

  • Ahn, Myung-Ju ; 
  • Han, Ji-Youn ; 
  • Kim, Sang-We ; 
  • Lee, Ki Hyeong ; 
  • Kim, Dong-Wan ; 
  • ... Lee, Jong-Seok ; 
  • ... Shin, Sang Won ; 
  • 외 13명
  • 2019-05-20
  • 미국
2015
Conference

Prevalence and comorbity of resistant hypertension in community practices

  • 2015-08-01
  • 영국
2007
Article

Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non-small-cell lung cancer

  • Park, Joon Oh ; 
  • Kim, Sang-We ; 
  • Ahn, Jin Seok ; 
  • Suh, Cheolwon ; 
  • Lee, Jung Shin ; 
  • ... Shin, Sang Won ; 
  • ... Lee, Jong Seok ; 
  • 외 10명
  • 2007-11-20
  • Journal of Clinical Oncology
  • American Society of Clinical Oncology